NASDAQ
Fate Therapeutics, Inc. (FATE) has a revenue compound annual growth rate of -26.71% over 5 years and 10.58% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.